Europe Facial Aesthetics Market Size, Share & Industry Trends Analysis Report By Product (Dermal fillers, Botulinum toxin, Microdermabrasion, Chemical peels), By Application, By End User, By Country and Growth Forecast, 2022 - 2028
The Europe Facial Aesthetics Market would witness market growth of 14.2% CAGR during the forecast period (2022-2028).
Botulinum toxin promotes young people to have such facial aesthetic procedures by reducing fine lines and wrinkles on the face. Furthermore, a variety of procedures include lip augmentation, regaining facial volume, and facial rejuvenation using facial aesthetics. Additionally, skin lightning, enhancing skin texture, and repairing facial wrinkles are done using whole field ablative, photo rejuvenation, and micro-ablative resurfacing.
As people age, their skin begins to lose its natural elasticity, leaving it looking dry and drab. However, there are a few facial cosmetic procedures that can help patients revive their skin, and apart from this, patients can get these procedures done at nearby their homes owing to the large availability of clinics and spas offering this type of service. Cosmetic procedures called facial aesthetics accentuate the inherent beauty and draw attention to the facial traits.
In recent decades, spa tourism has experienced significant development, actively embracing wellbeing and wellness. According to the National Library of Medicine, since there are over 300 spas in Germany and they collectively account for 30% of the total nights spent at German tourist locations, health tourism is essential to the German economy. It has an annual revenue of around US $36.4 billion and employs about 350,000 Germans directly or indirectly. These figures demonstrate that one of the most significant segments of the German tourism industry is healthcare and spas.
The Germany market dominated the Europe Facial Aesthetics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $989.9 million by 2028. The UK market is anticipated to grow at a CAGR of 13.3% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 15.1% during (2022 - 2028).
Based on Product, the market is segmented into Dermal fillers, Botulinum toxin, Microdermabrasion, Chemical peels, and Others. Based on Application, the market is segmented into Facial line correction treatment, Scar treatment, Lip enhancement, Restoration of volume or Fullness, and Others. Based on End User, the market is segmented into Hospitals, Specialty & Dermatology Clinics, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Merz Pharma GmbH & Co. KGaA, Galderma S.A., Candela Medical Corporation (Syneron Medical Ltd.), Teoxane S.A., Johnson & Johnson, Cynosure, LLC, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, and Fotona D.o.o.
Scope of the Study
Market Segments covered in the Report:
By Product
- Dermal fillers
- Botulinum toxin
- Microdermabrasion
- Chemical peels
- Others
- Facial line correction treatment
- Scar treatment
- Lip enhancement
- Restoration of volume or Fullness
- Others
- Hospitals
- Specialty & Dermatology Clinics
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- AbbVie, Inc.
- Merz Pharma GmbH & Co. KGaA
- Galderma S.A.
- Candela Medical Corporation (Syneron Medical Ltd.)
- Teoxane S.A.
- Johnson & Johnson
- Cynosure, LLC
- Bausch Health Companies, Inc.
- Ipsen Pharma Biotech SAS
- Fotona D.o.o.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Facial Aesthetics Market, by Product
- 1.4.2 Europe Facial Aesthetics Market, by Application
- 1.4.3 Europe Facial Aesthetics Market, by End User
- 1.4.4 Europe Facial Aesthetics Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market composition and scenario
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.2.4 Approvals and Trials
- 3.2.5 Geographical Expansions
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
- 3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2020, Jan – 2022, Mar) Leading Players
- Chapter 4. Europe Facial Aesthetics Market by Product
- 4.1 Europe Dermal fillers Market by Country
- 4.2 Europe Botulinum toxin Market by Country
- 4.3 Europe Microdermabrasion Market by Country
- 4.4 Europe Chemical peels Market by Country
- 4.5 Europe Others Market by Country
- Chapter 5. Europe Facial Aesthetics Market by Application
- 5.1 Europe Facial line correction treatment Market by Country
- 5.2 Europe Scar treatment Market by Country
- 5.3 Europe Lip enhancement Market by Country
- 5.4 Europe Restoration of volume or Fullness Market by Country
- 5.5 Europe Others Market by Country
- Chapter 6. Europe Facial Aesthetics Market by End User
- 6.1 Europe Hospitals Market by Country
- 6.2 Europe Specialty & Dermatology Clinics Market by Country
- 6.3 Europe Others Market by Country
- Chapter 7. Europe Facial Aesthetics Market by Country
- 7.1 Germany Facial Aesthetics Market
- 7.1.1 Germany Facial Aesthetics Market by Product
- 7.1.2 Germany Facial Aesthetics Market by Application
- 7.1.3 Germany Facial Aesthetics Market by End User
- 7.2 UK Facial Aesthetics Market
- 7.2.1 UK Facial Aesthetics Market by Product
- 7.2.2 UK Facial Aesthetics Market by Application
- 7.2.3 UK Facial Aesthetics Market by End User
- 7.3 France Facial Aesthetics Market
- 7.3.1 France Facial Aesthetics Market by Product
- 7.3.2 France Facial Aesthetics Market by Application
- 7.3.3 France Facial Aesthetics Market by End User
- 7.4 Russia Facial Aesthetics Market
- 7.4.1 Russia Facial Aesthetics Market by Product
- 7.4.2 Russia Facial Aesthetics Market by Application
- 7.4.3 Russia Facial Aesthetics Market by End User
- 7.5 Spain Facial Aesthetics Market
- 7.5.1 Spain Facial Aesthetics Market by Product
- 7.5.2 Spain Facial Aesthetics Market by Application
- 7.5.3 Spain Facial Aesthetics Market by End User
- 7.6 Italy Facial Aesthetics Market
- 7.6.1 Italy Facial Aesthetics Market by Product
- 7.6.2 Italy Facial Aesthetics Market by Application
- 7.6.3 Italy Facial Aesthetics Market by End User
- 7.7 Rest of Europe Facial Aesthetics Market
- 7.7.1 Rest of Europe Facial Aesthetics Market by Product
- 7.7.2 Rest of Europe Facial Aesthetics Market by Application
- 7.7.3 Rest of Europe Facial Aesthetics Market by End User
- Chapter 8. Company Profiles
- 8.1 AbbVie, Inc.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.1 Recent strategies and developments:
- 8.1.1.1 Acquisition and Mergers:
- 8.2 Merz Pharma GmbH & Co. KGaA
- 8.2.1 Company Overview
- 8.2.2 Recent strategies and developments:
- 8.2.2.1 Partnerships, Collaborations, and Agreements:
- 8.2.2.2 Product Launches and Product Expansions:
- 8.3 Galderma S.A.
- 8.3.1 Company Overview
- 8.3.2 Recent strategies and developments:
- 8.3.2.1 Partnerships, Collaborations, and Agreements:
- 8.3.2.2 Approvals and Trials:
- 8.3.2.3 Acquisition and Mergers:
- 8.4 Candela Medical Corporation (Syneron Medical Ltd.)
- 8.4.1 Company Overview
- 8.4.2 Recent strategies and developments:
- 8.4.2.1 Acquisition and Mergers:
- 8.4.2.2 Geographical Expansions:
- 8.5 Teoxane S.A.
- 8.5.1 Company Overview
- 8.5.2 Recent strategies and developments:
- 8.5.2.1 Partnerships, Collaborations, and Agreements:
- 8.5.2.2 Approvals and Trials:
- 8.6 Johnson and Johnson
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental &Regional Analysis
- 8.6.4 Research & Development Expenses
- 8.7 Cynosure, LLC
- 8.7.1 Company Overview
- 8.7.2 Recent strategies and developments:
- 8.7.2.1 Partnerships, Collaborations, and Agreements:
- 8.8 Bausch Health Companies, Inc.
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Segmental and Regional Analysis
- 8.8.4 Research & Development Expense
- 8.9 Ipsen Pharma Biotech SAS
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental and Regional Analysis
- 8.9.4 Research & Development Expense
- 8.10. Fotona D.o.o.
- 8.10.1 Company Overview
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook